The Taliesin architect resided in this aerie for five years — and now it can belong to someone new for $18.9 million.
Skip the spendy seatings and contrived celebrations and take advantage of the many inspiring, exciting, offbeat, and romantic ...
Guggenheim adjusted its outlook for New York Times Company (NYSE:NYT), reducing the price target from $55.00 to $52.00 while maintaining a Neutral rating on the stock. According to InvestingPro data, ...
Guggenheim lowered the firm’s price target on New York Times (NYT) to $52 from $55 and keeps a Neutral rating on the shares. Core news softness ...
The private-credit arm of Guggenheim Investments has employed a novel tool to attract institutional investors to its newest fund as it contends with fierce fundraising competition from other ...
NEW YORK, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Guggenheim Investments today announced that certain closed-end funds have declared their distributions. The table below summarizes the distribution ...
Tenax Therapeutics’ management will also participate in one-on-one investor meetings. To request a one-on-one meeting at the conference, please contact your Guggenheim representative. The live and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results